These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 2314480

  • 1. NG-nitro-L-arginine (N5-[imino(nitroamino)methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine.
    Mülsch A, Busse R.
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):143-7. PubMed ID: 2314480
    [Abstract] [Full Text] [Related]

  • 2. NG-nitro-L-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothelium-derived relaxing factor release in the isolated rabbit heart.
    Lamontagne D, Pohl U, Busse R.
    Pflugers Arch; 1991 Apr; 418(3):266-70. PubMed ID: 1649992
    [Abstract] [Full Text] [Related]

  • 3. Attenuation of vasoconstriction by endogenous nitric oxide in rat caudal artery.
    Vo PA, Reid JJ, Rand MJ.
    Br J Pharmacol; 1992 Dec; 107(4):1121-8. PubMed ID: 1467834
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
    Vargas HM, Cuevas JM, Ignarro LJ, Chaudhuri G.
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1208-15. PubMed ID: 1646327
    [Abstract] [Full Text] [Related]

  • 5. Nitric oxide synthesis in endothelial cytosol: evidence for a calcium-dependent and a calcium-independent mechanism.
    Mülsch A, Bassenge E, Busse R.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):767-70. PubMed ID: 2576763
    [Abstract] [Full Text] [Related]

  • 6. The L-arginine-nitric oxide pathway in the canine femoral vascular bed: in vitro and in vivo experiments.
    Richard V, Gosgnach M, Drieu la Rochelle C, Giudicelli JF, Berdeaux A.
    Fundam Clin Pharmacol; 1991 Dec; 5(9):777-88. PubMed ID: 1794833
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
    Thiemermann C, Mustafa M, Mester PA, Mitchell JA, Hecker M, Vane JR.
    Br J Pharmacol; 1991 Sep; 104(1):31-8. PubMed ID: 1786515
    [Abstract] [Full Text] [Related]

  • 8. Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.
    Hecker M, Mitchell JA, Harris HJ, Katsura M, Thiemermann C, Vane JR.
    Biochem Biophys Res Commun; 1990 Mar 30; 167(3):1037-43. PubMed ID: 2322257
    [Abstract] [Full Text] [Related]

  • 9. Endothelium-dependent relaxation to acetylcholine in bovine oviductal arteries: mediation by nitric oxide and changes in apamin-sensitive K+ conductance.
    García-Pascual A, Labadía A, Jimenez E, Costa G.
    Br J Pharmacol; 1995 Aug 30; 115(7):1221-30. PubMed ID: 7582549
    [Abstract] [Full Text] [Related]

  • 10. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.
    Moore PK, al-Swayeh OA, Chong NW, Evans RA, Gibson A.
    Br J Pharmacol; 1990 Feb 30; 99(2):408-12. PubMed ID: 2328404
    [Abstract] [Full Text] [Related]

  • 11. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation.
    Rees DD, Palmer RM, Hodson HF, Moncada S.
    Br J Pharmacol; 1989 Feb 30; 96(2):418-24. PubMed ID: 2924084
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
    Crack P, Cocks T.
    Br J Pharmacol; 1992 Oct 30; 107(2):566-72. PubMed ID: 1384915
    [Abstract] [Full Text] [Related]

  • 14. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
    Zembowicz A, Swierkosz TA, Southan GJ, Hecker M, Vane JR.
    Br J Pharmacol; 1992 Dec 30; 107(4):1001-7. PubMed ID: 1281716
    [Abstract] [Full Text] [Related]

  • 15. In vitro and ex vivo inhibitory effects of L- and D-enantiomers of NG-nitro-arginine on endothelium-dependent relaxation of rat aorta.
    Wang YX, Poon CI, Pang CC.
    J Pharmacol Exp Ther; 1993 Apr 30; 265(1):112-9. PubMed ID: 8473999
    [Abstract] [Full Text] [Related]

  • 16. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta.
    Zembowicz A, Hatchett RJ, Jakubowski AM, Gryglewski RJ.
    Br J Pharmacol; 1993 Sep 30; 110(1):151-8. PubMed ID: 7693274
    [Abstract] [Full Text] [Related]

  • 17. Role of the endothelium and cyclic GMP in renal vasodilator responses to cryptolepine in rats.
    Oyekan AO.
    J Cardiovasc Pharmacol; 1994 Apr 30; 23(4):602-11. PubMed ID: 7516010
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of endothelial nitric oxide biosynthesis by N-nitro-L-arginine.
    Dubbin PN, Zambetis M, Dusting GJ.
    Clin Exp Pharmacol Physiol; 1990 Apr 30; 17(4):281-6. PubMed ID: 2347118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.